Accelerate your Peptide Mapping with CeleramAb
Stop Waiting for Peptide Maps.
Start Analyzing.
Transform your analytical pipeline with the RaPiD-mAb-MS™ platform. Achieve a 50X increase in throughput and a >2X reduction in cost by eliminating the liquid chromatography (LC) bottleneck.
Johnson & Johnson
The RaPiD-mAb-MS platform™ eliminates the traditional chromatography bottleneck, allowing us to screen and characterize antibodies at a scale and speed that were previously unattainable.
Harsha Gunawardena, PhD
Proteomics Group Leader
Johnson & Johnson Innovative Medicine
Millipore Sigma
The ability to acquire peptide mapping data in just 1-2 minutes while maintaining high sequence coverge is remarkable. The CeleramAb team has been extremely responsive and supportive throughout onboarding and implementation, with an exceptional level of customer engagement and technical support.
Pei Liu
Principal Scientist
